197 related articles for article (PubMed ID: 24376734)
1. PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma.
Ameis HM; Drenckhan A; von Loga K; Escherich G; Wenke K; Izbicki JR; Reinshagen K; Gros SJ
PLoS One; 2013; 8(12):e83701. PubMed ID: 24376734
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
Russell HV; Hicks J; Okcu MF; Nuchtern JG
J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
[TBL] [Abstract][Full Text] [Related]
3. Influence of hypoxia-dependent factors on the progression of neuroblastoma.
Ameis HM; Drenckhan A; Freytag M; Izbicki JR; Supuran CT; Reinshagen K; Holland-Cunz S; Gros SJ
Pediatr Surg Int; 2016 Feb; 32(2):187-92. PubMed ID: 26510737
[TBL] [Abstract][Full Text] [Related]
4. Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer.
Zieker D; Königsrainer I; Tritschler I; Löffler M; Beckert S; Traub F; Nieselt K; Bühler S; Weller M; Gaedcke J; Taichman RS; Northoff H; Brücher BL; Königsrainer A
Int J Cancer; 2010 Mar; 126(6):1513-20. PubMed ID: 19688824
[TBL] [Abstract][Full Text] [Related]
5. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
Geminder H; Sagi-Assif O; Goldberg L; Meshel T; Rechavi G; Witz IP; Ben-Baruch A
J Immunol; 2001 Oct; 167(8):4747-57. PubMed ID: 11591806
[TBL] [Abstract][Full Text] [Related]
6. CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications.
Airoldi I; Raffaghello L; Piovan E; Cocco C; Carlini B; Amadori A; Corrias MV; Pistoia V
Clin Cancer Res; 2006 Jan; 12(1):77-82. PubMed ID: 16397027
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and induce invasiveness in neuroblastoma cell lines.
Shankar V; Hori H; Kihira K; Lei Q; Toyoda H; Iwamoto S; Komada Y
PLoS One; 2015; 10(3):e0120069. PubMed ID: 25774696
[TBL] [Abstract][Full Text] [Related]
8. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α.
Zhi Y; Lu H; Duan Y; Sun W; Guan G; Dong Q; Yang C
Int J Mol Med; 2015 Feb; 35(2):349-57. PubMed ID: 25503960
[TBL] [Abstract][Full Text] [Related]
10. The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.
Meier R; Mühlethaler-Mottet A; Flahaut M; Coulon A; Fusco C; Louache F; Auderset K; Bourloud KB; Daudigeos E; Ruegg C; Vassal G; Gross N; Joseph JM
PLoS One; 2007 Oct; 2(10):e1016. PubMed ID: 17925864
[TBL] [Abstract][Full Text] [Related]
11. A glycolytic mechanism regulating an angiogenic switch in prostate cancer.
Wang J; Wang J; Dai J; Jung Y; Wei CL; Wang Y; Havens AM; Hogg PJ; Keller ET; Pienta KJ; Nor JE; Wang CY; Taichman RS
Cancer Res; 2007 Jan; 67(1):149-59. PubMed ID: 17210694
[TBL] [Abstract][Full Text] [Related]
12. PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis.
He Y; Wang X; Lu W; Zhang D; Huang L; Luo Y; Xiong L; Li H; Zhang P; Li Q; Liang S
Cell Death Dis; 2022 Feb; 13(2):118. PubMed ID: 35121728
[TBL] [Abstract][Full Text] [Related]
13. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
[TBL] [Abstract][Full Text] [Related]
14. PGK1 a potential marker for peritoneal dissemination in gastric cancer.
Zieker D; Königsrainer I; Traub F; Nieselt K; Knapp B; Schillinger C; Stirnkorb C; Fend F; Northoff H; Kupka S; Brücher BL; Königsrainer A
Cell Physiol Biochem; 2008; 21(5-6):429-36. PubMed ID: 18453750
[TBL] [Abstract][Full Text] [Related]
15. [Influence of phosphoglycerate kinase 1 on metastasis and invasion of hepatoma cells and prognosis of liver cancer].
Zhang L; Wang YC; Xie XY; Chen J; Gao DM; Ren ZG
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):446-451. PubMed ID: 28763863
[No Abstract] [Full Text] [Related]
16. Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.
Cabioglu N; Sahin A; Doucet M; Yavuz E; Igci A; O Yildirim E; Aktas E; Bilgic S; Kiran B; Deniz G; Price JE
Clin Exp Metastasis; 2005; 22(1):39-46. PubMed ID: 16132577
[TBL] [Abstract][Full Text] [Related]
17. PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.
Fu D; He C; Wei J; Zhang Z; Luo Y; Tan H; Ren C
Cell Physiol Biochem; 2018; 51(5):2434-2444. PubMed ID: 30537744
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study.
Osman J; Galli S; Hanafy M; Tang X; Ahmed A
Clin Transl Oncol; 2013 Nov; 15(11):953-8. PubMed ID: 23553333
[TBL] [Abstract][Full Text] [Related]
19. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma.
Laverdiere C; Hoang BH; Yang R; Sowers R; Qin J; Meyers PA; Huvos AG; Healey JH; Gorlick R
Clin Cancer Res; 2005 Apr; 11(7):2561-7. PubMed ID: 15814634
[TBL] [Abstract][Full Text] [Related]
20. Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.
Sun S; Liang X; Zhang X; Liu T; Shi Q; Song Y; Jiang Y; Wu H; Jiang Y; Lu X; Pang D
Br J Cancer; 2015 Apr; 112(8):1332-9. PubMed ID: 25867275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
